News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Country star will rock Asbury Park for brain cancer research benefit

Posted on: 12/16/2008

Country star will rock Asbury Park for brain cancer research benefit

By Nancy Shields • COASTAL MONMOUTH BUREAU • December 16, 2008


ASBURY PARK — "Asbury Rocks for a Cancer Cure," featuring Grammy Award-nominated country music singer James Otto, will be held at 7 p.m. Sunday at Paramount Theatre.

The concert was organized by local music impresario Andy Feldman of Middletown to benefit the David S. Zocchi Brain Tumor Center at Monmouth Medical Center and the Duke University brain cancer research center.

Feldman, who is 46 and grew up in Deal, said he wanted to produce the concert because of the loss of two childhood friends from Deal, Greg Rubin and his sister, Carolyn Kelly Wallach, to brain cancer.

Rubin died July 9, 1984, at age 22, Feldman said. Twenty years later on the same date, July 9, 2004, Rubin's sister, Carolyn, also died of brain cancer at age 43. She was a producer of the "Martha Stewart Living" show.

Warner Bros. Records recording artist Otto received his first two Grammy nominations this month in the categories of best male country vocal performance for "Just Got Started Lovin' You," and for best country song for his contribution on Jamey Johnson's "In Color."

The concert also will feature local artist Val Emmich, who recently joined the cast of the ABC show "Ugly Betty." He also has appeared on "30 Rock" and has released six albums.

Other performers announced for the upcoming concert include Arlan Feiles and his Lone Orchestra, John Eddie, Glen Burtnik, Allie Moss, Rick Barry and Rob Tanico.

Tickets cost $17 and are on sale through and

Feldman said he has a goal of raising $100,000, with $75,000 to go to Monmouth Medical Center and $25,000 to Duke.

The David S. Zocchi Brain Tumor Center at Monmouth's Leon Hess Cancer Center is the region's first facility to offer a multidisciplinary approach for leading-edge treatment of primary and metastatic tumors of the central nervous system, as well as neurological complications of cancer that has spread to other regions of the body, according to a news release.

Feldman said he is setting aside 200 tickets for cancer survivors. He can be reached at (732) 796-4914.


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557